Hemerion Therapeutics Email Format

Biotechnology ResearchHauts-de-france, France11-50 Employees

Hemerion Therapeutics is a clinical-stage biotechnology company focused on developing treatments for brain cancer, with a particular emphasis on glioblastoma. Based in Lille, in the Hauts-de-France region of France, the company emerges from a collaboration among the University of Lille, Inserm, and the University Hospital of Lille, underpinned by more than a decade of academic and clinical research. The firm holds a unique technology that has been evaluated as a frontline option for treating brain tumors, aiming to improve patient outcomes in glioblastoma. It operates in the biotechnology research space, translating its clinical-stage work into potential therapies for brain cancer. A notable milestone in its development was the FDA clearance of an IND application for its Pentalafen / Heliance combination product in the treatment of glioblastoma.

Sign up for free to view info

Company overview Employee directory